Update on Chimeric Antigen Receptor (CAR) T-Cell Therapy for Blood Cancers

For questions regarding the program or registration or for grievances and requests for accommodations for those with disabilities, please contact

Julie Jakicic 914-892-8952 or Julie.Jakicic@lls.org